The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Expected Market Size Of The Candidiasis Therapeutics Market In 2026 And How Much Will It Reach By 2030?
The cannabinoids market size has experienced significant expansion in recent years. It is projected to grow from $47.03 billion in 2025 to $56.75 billion in 2026, achieving a compound annual growth rate (CAGR) of 20.7%. The expansion observed historically is attributable to several factors, including the increasing legalization of medical cannabis programs, the rising prevalence of chronic pain and cancer treatments, the growing acceptance of alternative therapies, the expansion of hospital pharmacy distribution networks, and the development of standardized cannabinoid formulations.
The cannabinoids market size is projected for substantial expansion over the coming years. By 2030, this market is anticipated to reach a valuation of $120.57 billion, exhibiting a compound annual growth rate (CAGR) of 20.7%. This expansion during the forecast period is fueled by several factors, including the increased scope of clinical investigations into cannabinoids, a growing need for pharmaceutical-grade cannabinoid items, clearer regulatory frameworks across different regions, the emergence of personalized cannabinoid treatments, and higher investments in the infrastructure for cannabinoid production. Key developments anticipated within the same period encompass the rising integration of cannabinoid-based therapies in medical practice, an escalating preference for CBD-dominant offerings, the expanding application of cannabinoids in managing chronic diseases, the broadening of regulated cannabinoid supply networks, and a heightened emphasis on ensuring product standardization and purity.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13182&type=smp
What Are The Main Drivers Accelerating The Growth Of The Candidiasis Therapeutics Market?
The increasing incidence of chronic illnesses is anticipated to boost the cannabinoid market. These are conditions enduring for a year or more, necessitating continuous medical care. A systematic review of randomized controlled trials investigated the efficacy of various cannabinoids, including smoked marijuana, cannabis-based oromucosal extracts, nabilone, dronabinol, and a novel THC analogue, for managing chronic noncancer pain. For example, as reported by the Centers for Disease Control and Prevention (CDC), a US-based federal agency, in April 2025, it was found that in 2023, around 194 million U.S. adults, representing 76.4% of the population, indicated experiencing at least one chronic ailment. This condition was prevalent among 59.5% of young adults, 78.4% of midlife adults, and 93.0% of older adults. Consequently, the growing occurrence of chronic diseases is fueling the expansion of the cannabinoid market.
What Segment Types Are Included In The Candidiasis Therapeutics Market Analysis?
The candidiasis therapeutics market covered in this report is segmented –
1) By Treatment Type: Medication, Supportive Therapy
2) By Anatomy Type: Oral Candidiasis, Vulvovaginal Candidiasis, Cutaneous Candidiasis, Invasive Candidiasis, Systemic Candidiasis
3) By Mode Of Administration: Injectable, Oral, Other Mode Of Administrations
4) By Patient Population: Adults, Pediatrics
5) By End User: Hospitals, Specialty Clinics, Other End Users
Subsegments:
1) By Medication: Antifungal Drugs, Topical Treatments, Systemic Treatments
2) By Supportive Therapy: Probiotics, Symptom Management Therapies, Adjunct Nutritional Support
Which Trends Are Expected To Shape The Candidiasis Therapeutics Market?
Leading companies within the cannabinoids market are concentrating on developing innovative solutions, such as rapid-onset cannabinoids, to enhance the efficacy and speed of their therapeutic benefits. These fast-acting cannabinoids are formulations engineered to produce quicker therapeutic effects after consumption compared to traditional delivery methods. For example, in August 2024, Rare Cannabinoid, a US-based health and wellness company, introduced Fast-Acting Nano THC + CBC Mood Mints, expanding its popular mood product line with an innovative delivery method. These mints are formulated to deliver rapid effects, allowing users to experience the benefits of delta-9-THC and cannabichromene (CBC) within 15 to 30 minutes, a significant improvement over the typical 30 to 90 minutes for traditional edibles. By utilizing advanced nanotechnology, the mints provide flexible dosing options suitable for both microdosing and individualized needs.
Which Industry Players Are Present In The Candidiasis Therapeutics Market?
Major companies operating in the candidiasis therapeutics market are Pfizer Inc., Biocon Limited, Torrent Pharmaceuticals Ltd., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca plc, GSK plc, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Cipla Inc., Lupin Limited, Basilea Pharmaceutica Ltd., WOCKHARDT Limited, Cidara Therapeutics Inc., Amplyx Pharmaceuticals Inc., SCYNEXIS Inc., Mycovia Pharmaceuticals Inc., NovaBiotics Inc., Matinas BioPharma Holdings Inc.
Access The Complete Candidiasis Therapeutics Market Report:
https://www.thebusinessresearchcompany.com/report/candidiasis-therapeutics-global-market-report
Which Region Has The Strongest Presence In The Candidiasis Therapeutics Market?
North America was the largest region in the candidiasis therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the candidiasis therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Candidiasis Therapeutics Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=13182&type=smp
Browse Through More Reports Similar to the Global Candidiasis Therapeutics Market 2026, By The Business Research Company
High Level Disinfection Services Global Market Report 2026
Uv Disinfection Equipment Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/uv-disinfection-equipment-global-market-report
Pseudomonas Aeruginosa Infection Treatment Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model